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OBJECTIVES The goal of this study was to evaluate the relative effects of hyperglycemia and hyperinsu-
linemia on postprandial remnant lipoprotein (RLP) concentrations in newly diagnosed type
2 diabetics.
BACKGROUND Increases in fasting RLP concentration have been described in type 2 diabetics, as well as in
insulin-resistant nondiabetics. Given the atherogenicity of RLPs, we have extended these
observations by assessing postprandial RLP concentrations and observing that hyperglycemia
was necessary for the increase in RLP concentrations.
METHODS Patients with type 2 diabetes were subdivided on the basis of their plasma insulin response to
oral glucose into hyperinsulinemic (H-DM) and normoinsulinemic (N-DM) groups of 15
patients each. Plasma triglyceride (TG), RLP-TG and RLP cholesterol (RLP-C) concen-
trations were determined before and 2 and 4 h after an oral fat load in these patients and 10
control (CTL) subjects.
RESULTS Plasma TG, RLP-TG and RLP-C concentrations peaked 2 h after the fat load in the CTL
group, returning to baseline within 4 h. In contrast, concentrations of these variables
increased throughout the 4-h study in both groups of patients with type 2 diabetes. Total
integrated plasma RLP-TG and RLP-C responses above baseline after the oral fat load were
significantly higher in the H-DM group compared with the CTL (p  0.019 and 0.009,
respectively) or N-DM (p  0.026 and 0.029, respectively) groups. Post-heparin lipoprotein
lipase activities and apo E phenotypes were similar in the H-DM and N-DM groups.
CONCLUSIONS Remnant lipoprotein response to an oral fat load is significantly increased in hyperinsulinemic
patients with type 2 diabetes. These changes may increase the risk of coronary heart disease
in these individuals. (J Am Coll Cardiol 2001;38:1628–32) © 2001 by the American College
of Cardiology
The introduction of a technique based upon the use of
monoclonal antibodies to apolipoproteins A-1 and B-100
(1–3) has provided a method for isolating and quantifying
the plasma concentration of remnant lipoproteins (RLPs).
Published results using this method have demonstrated that
fasting RLP concentrations are increased in patients with
either type 2 diabetes or impaired glucose tolerance (4), as
well as in insulin-resistant, nondiabetic individuals (5).
Given evidence that the postprandial accumulation of tri-
glyceride (TG)-rich lipoproteins is atherogenic (6–11) and
that concentration of these particles is elevated in insulin-
resistant states (4,5,12), it seemed important to extend these
observations of RLP concentrations beyond the fasting
state. In particular, knowledge of the changes in postpran-
dial RLP concentrations in patients with type 2 diabetes
might be particularly interesting in lieu of our incomplete
understanding of why the prevalence of atherogenesis is
increased in these patients.
A second goal of this study was to gain additional insight
into the relative importance of hyperglycemia versus hyper-
insulinemia in the modulation of RLP metabolism. To
accomplish this task, patients with newly diagnosed type 2
diabetes were subdivided into two groups on the basis of
their plasma insulin response to an oral glucose challenge—
hyperinsulinemic (H-DM) and normoinsulinemic (N-
DM). A comparison of the RLP responses to an oral fat
load of these two groups, as well as that of a third group of
healthy, nondiabetic volunteers (CTL), forms the substance
of this report.
METHODS
The study population consisted of 40 individuals: 30 pa-
tients with type 2 diabetes newly diagnosed at the time of an
annual medical evaluation and 10 healthy, nondiabetic
volunteers. The 30 patients with type 2 diabetes were
selected from a larger group of 66 individuals who, as part of
their annual evaluation, had been diagnosed as having type
2 diabetes on the basis of an oral glucose tolerance test (13).
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From this group of 66 individuals, 15 were selected on the
basis of having a plasma insulin concentration 120 min after
the oral glucose load 80 U/ml, and a sum of the six
insulin concentrations determined before and 30, 60, 90,
120 and 180 min after the oral glucose load 300 U/ml.
From the remaining newly diagnosed patients, 15 additional
individuals were selected with having insulin concentration
120 min after the oral glucose load 60 U/ml, summed
values during the glucose tolerance test 250 U/ml and
comparable to the first group in terms of age, gender and
body mass index (BMI). The plasma glucose and insulin
concentrations of the two groups of patients with type 2
diabetes are shown in Figure 1. It is apparent that the
plasma glucose concentrations were essentially identical,
whereas their insulin concentrations differed widely. The
group with the highest insulin concentration (summed
insulin concentration  447  34 U/ml) was defined as
being H-DM, and the other group (summed insulin con-
centrations 198 16 U/ml) was classified as N-DM. In
this fashion we were able to create two groups of patients
with type 2 diabetes, dichotomous for only their plasma
insulin response to an oral glucose load.
All of the patients with type 2 diabetes were newly
diagnosed and were taking no medications that affect
carbohydrate or lipoprotein metabolism; the oral fat toler-
ance test (OFTT) was performed within 30 days of the
positive oral glucose tolerance test. Glycosylated hemoglo-
bin concentrations (HbA1c) (mean  SEM) were 5.4 
0.1%, 5.2  0.1% and 5.0  0.2% in the N-DM, H-DM
and CTL groups, respectively, and these differences were
not statistically significant. The measurement of RLP con-
centrations in response to an oral fat load were performed as
previously described (14) in the 30 patients with type 2
diabetes and 10 healthy, nondiabetic volunteers. Briefly,
after an overnight fast, each subject ingested 17 g of fat/m2
surface area (OFTT cream, Jomo Food Industry, Takashi,
Japan) containing 57% water, 33% lipid, 3% protein and 7%
carbohydrate (14). The fat distribution in the cream is
64.3% saturated, 29.3% monounsaturated and 3.5% poly-
unsaturated. Venous blood samples were obtained before
and 2 and 4 h after the oral fat load to determine total
cholesterol (C) (15), triglyceride (16), high-density lipopro-
tein (HDL) cholesterol (17), glucose (18), insulin (19) and
remnant lipoprotein cholesterol (RLP-C) and remnant
lipoprotein triglyceride (RLP-TG) concentrations (1–3).
The decision to limit this study to 4 h was based on results
in normal individuals, showing that RLP-C and RLP-TG
concentrations peaked at 2 h after the fat load and had
returned to baseline at 4 h. The plasma TG, RLP-C and
RLP-TG responses to the fat load were quantified by
determining the total integrated response above baseline
during the 4 h of the study.
Plasma lipoprotein lipase (LPL) concentration was esti-
mated on a separate day. After an overnight fast, subjects
were injected intravenously with heparin (30 U/kg intrave-
nous), and a blood sample was drawn 15 min later for
measurement of lipoprotein lipase (20). Finally, apolipopro-
tein E phenotype was also analyzed (21) from the fasting
plasma by isoelectric focusing electrophoresis (phenotyping
Apo E IEF System, Jyoko, Japan).
Data are expressed as mean  SEM. The statistical
significance of differences between the experimental groups
was determined by one-way analysis of variance (ANOVA).
Abbreviations and Acronyms
apo  apolipoprotein
BMI  body mass index
C  cholesterol
CHD  coronary heart disease
CTL  healthy volunteers
HDL  high-density lipoprotein
H-DM  hyperinsulinemic patient with
type 2 diabetes
LPL  lipoprotein lipase
N-DM  normoinsulinemic patient with
type 2 diabetes
OPTT  oral fat tolerance test
RLP  remnant lipoprotein
RLP-C  remnant lipoprotein cholesterol
RLP-TG  remnant lipoprotein triglyceride
TG  triglyceride
Figure 1. Plasma glucose and insulin concentrations before and after a 75 g oral glucose load in hyperinsulinemic patients with type 2 diabetes (H-DM)
and normoinsulinemic patients with type 2 diabetes (N-DM) .
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Scheffe´ F test method was used as a post hoc test if any
differences were noted with ANOVA.
RESULTS
The baseline characteristics of the three study groups are
shown in Table 1. It can be seen that the two groups of patients
with type 2 diabetes were comparable in terms of age, gender
distribution and BMI. Furthermore, the distribution of apo E
phenotype was similar in the two diabetic patient groups.
However, by selection, the two groups of patients with type 2
diabetes differed dramatically with regard to their plasma
insulin response to oral glucose (Fig. 1).
Fasting lipid and lipoprotein concentrations of the three
study groups are listed in Table 2. When analyzed by
one-way ANOVA, differences were noted between the total
C (p  0.035), TG (p  0.073) and RLP-C (p  0.016)
concentrations of the three experimental groups. Hyperin-
sulinemic patients with type 2 diabetes, as a group, had
higher plasma C (p 0.059) and RLP-C (p 0.009) when
compared with the N-DM group (Scheffe´ post hoc meth-
od). When two subgroups of patients with type 2 diabetes
were compared with the CTL population, the only signif-
icant differences were higher values in the H-DM patients
for total C (p  0.016), TG (p  0.025) and RLP-C (p 
0.025) concentrations. There were no differences between
the N-DM group and the CTL group.
Since concentrations of total C, HDL-C, glucose and
insulin did not change substantially during the OFTT, only
the TG, RLP-C and RLP-TG responses to the fat load will
be shown. These data are seen in Figure 2. Fasting concen-
trations of TG, RLP-TG and RLP-C were highest in the
H-DM group before the fat load, and the results in Figure
2 indicate that this difference persisted 2 and 4 h after the
oral fat load. The most obvious difference between the oral
fat load responses of the three groups is that the concen-
trations of TG, RLP-TG and RLP-C increased progres-
sively during the 4 h in both groups of patients with type 2
diabetes, whereas levels for the CTL group peaked 2 h after
the fat load and returned to baseline levels within 4 h.
To evaluate the statistical significance of the response
curves shown in Figure 2, we calculated the total incremen-
tal response above baseline. These comparisons are shown in
Table 3, and the ANOVA analysis demonstrated that there
were no statistically significant differences between the total
TG responses in the three groups. However, there were
significant differences between the RLP-TG (p  0.027)
and RLP-C (p 0.016) concentrations in the three groups.
Furthermore, the post hoc analysis showed that the H-DM
group had significantly higher RLP-TG and RLP-C con-
centrations than the N-DM (p  0.026 and p  0.029,
respectively) or the CTL (p  0.19 and p  0.009,
respectively) group. However, the post hoc analysis indi-
cated that there were no differences between the CTL
population and the N-DM group for any of the variables.
Despite the obvious changes in plasma concentrations of
TG, RLP-TG and RLP-C concentrations during the fat
tolerance test, the values for postheparin lipoprotein lipase
activity were essentially identical in the H-DM (282  26
ng/ml) and N-DM (255  24 ng/ml) groups. Finally, apo
E phenotypes were similar in the H-DM and N-DM
groups, with 10 and nine individuals apo E 3/3 and five and
six subjects apo E 4/3, respectively.
DISCUSSION
Postprandial RLP concentrations of the three groups.
The results of this study have provided straightforward
answers to the two questions posed in the introduction. In
the most general sense, it was shown that the TG, RLP-TG
and RLP-C concentrations before and after the oral fat load
were highest in the H-DM group, lowest in the CTL
Table 2. Comparison of the Lipid and Lipoprotein Concentrations in the Three Study Groups* (Mean  SEM)
Variable
Group p Values
H-DM N-DM CTL ANOVA
DM
(H vs. N) H vs. CTL N vs. CTL
Cholesterol (mg/dl) 220  6 196  10 185  8 0.035 0.059 0.016 0.363
LDL cholesterol (mg/dl) 129  10 116  9 109  10 0.248 0.349 0.104 0.418
HDL cholesterol (mg/dl) 61  4 57  4 63  3 0.523 0.371 0.794 0.315
TG (mg/dl) 151  24 118  10 83  10 0.073 0.186 0.025 0.233
RLP-TG (mg/dl) 19.4  4.6 14.0  2.0 13.5  4.1 0.462 0.278 0.321 0.93
RLP-C (mg/dl) 4.9  0.5 3.5  0.3 3.5  0.4 0.016 0.009 0.025 0.976
*The results of each of the three groups are compared with the other two.
ANOVA: p values were calculated by one-way ANOVA and a value 0.05 indicates that a difference exists between the three groups. Scheffe´’s post hoc method was used
to define the significance of the difference between any two of the three groups.
ANOVA  analysis of variance; C  cholesterol; CTL  normal volunteers; DM  patients with type 2 diabetes; HDL  high-density lipoprotein; H-DM 
hyperinsulinemic patients with type 2 diabetes; LDL  low-density lipoprotein; N-DM  normoinsulinemic patients with type 2 diabetes; RLP  remnant lipoprotein; TG 
triglyceride.
Table 1. Baseline Characteristics
Variable
Group
H-DM
(n  15)
N-DM
(n  15)
CTL
(n  10)
Age (yrs) 57  2 57  2 33  1
Gender (male/female) 9/6 9/6 6/4
BMI (kg/m2) 25.7  0.7 24.6  0.6 22.9  0.5
BMI  body mass index; CTL  normal volunteers; H-DM  hyperinsulinemic
patients with type 2 diabetes; N-DM  normoinsulinemic patients with type 2
diabetes.
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subjects, with values of the N-DM patients being interme-
diate. To a large extent, the differences between the three
groups was due to the fact that the TG, RLP-TG and
RLP-C concentrations continued to increase throughout
the 4 h period after the fat load in the H-DM and N-DM
groups, whereas the concentrations of all three variables
peaked at 2 h in the CTL group, returning to baseline by
the 4 h time point. As a consequence, the total integrated
response above baseline after the oral fat load was signifi-
cantly higher in the H-DM compared with the CTL group
for the RLP-TG (p  0.019) and RLP-C (p  0.009)
concentrations. Although the mean integrated responses of
all three variables was somewhat higher than the CTL
values in the N-DM group, none of the differences were of
even marginal significance.
Differences between the RLP concentrations of the two
diabetic groups. If we now focus on comparisons of the
two groups of patients with type 2 diabetes, the impact of
the differences in plasma insulin concentrations on the
results of the fat tolerance test is apparent from Figure 2.
First, the concentrations of TG, RLP-TG and RLP-C are
higher at every time point in the H-DM patients compared
with the N-DM patients. Furthermore, the total integrated
RLP-TG (p  0.026) and RLP-C (p  0.029) responses
above baseline were significantly higher in the H-DM
group (Table 3). It should be noted that the fasting plasma
TG concentrations were not significantly different in the
two groups (Table 2), suggesting that the differences noted
were not a simple function of an enlarged fasting plasma
TG pool size. Furthermore, the fact that the LPL levels
were the same in the two diabetic groups suggests that
differences in the level of this enzyme was not the reason for
the higher RLP levels in the H-DM group.
Physiological relevance. The results presented show that
both hyperglycemia and hyperinsulinemia modulate post fat
load RLP concentrations. Specifically, RLP-TG and
RLP-C concentrations increased progressively throughout
the OFTT in both groups of patients with diabetes, whereas
concentrations had returned to baseline within 4 h in the
CTL group, irrespective of the degree of hyperinsulinemia
present in patients with type 2 diabetes. Thus, in this case,
hyperglycemia, per se, appeared to modulate the RLP
response to an oral fat load. On the other hand, although
the two groups of patients with type 2 diabetes were equally
hyperglycemic, RLP-TG and RLP-C concentrations were
higher before and after the fat load in the H-DM compared
with the N-DM group. Since the only obvious difference
between the two groups of patients with type 2 diabetes was
in the plasma insulin concentrations, the possibility that the
degree of hyperinsulinemia will lead to increases in RLP
concentrations, independently of the degree of glycemia, is
worthy of consideration.
Clinical relevance. The results provide potentially impor-
tant clinical information concerning the link between hy-
Figure 2. Plasma triglyceride, remnant lipoprotein triglyceride (RLP-TG) and remnant lipoprotein cholesterol (RLP-C) concentrations before and after
an oral fat load in normal volunteers (CTL) and in hyperinsulinemic patients with type 2 diabetes (H-DM) and normoinsulinemic patients with type 2
diabetes (N-DM).
Table 3. Comparison of the Plasma Triglyceride and Remnant Lipoprotein Responses in the Three Study Groups (Mean  SEM)
to the Oral Fat Load*
Variable
Group p Values
H-DM N-DM CTL ANOVA
DM
(H vs. N)
H-DM vs.
CTL
N-DM vs.
CTL
TG (mg/dlh) 134.9  26.8 119.3  17.5 74.6  19.1 0.254 0.604 0.102 0.222
RLP-TG (mg/dlh) 150.2  25.9 86.9  14.2 70.0  14.9 0.027 0.026 0.019 0.608
RLP-C (mg/dlh) 9.1  1.4 5.5  1.0 3.9  0.9 0.016 0.029 0.009 0.365
*The results of each of the three groups are being compared with the results of the other two groups
ANOVA: p values were calculated by one-way ANOVA and a value 0.05 indicates that a difference exists between the three groups. Scheffe´’s post hoc method was used
to define the significance of the difference between any two of the three groups.
ANOVA  analysis of variance; CTL  normal volunteers; DM  patients with type 2 diabetes; H-DM  hyperinsulinemic patients with type 2 diabetes; N-DM 
normoinsulinemic patients with type 2 diabetes; RLP-C  remnant lipoprotein cholesterol; RLP-TG  remnant lipoprotein triglyceride; TG  triglyceride.
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perinsulinemia and coronary heart disease (CHD) in pa-
tients with type 2 diabetes. The results of the United
Kingdom Prospective study (22) demonstrated that im-
proved glycemic control was much more effective in reduc-
ing microangiopathy than macrovascular disease in patients
with type 2 diabetes. In this context, the recent results of a
prospective study (23) showing that hyperinsulinemia sig-
nificantly predicted CHD in patients with type 2 diabetes is
of interest. The notion that atherogenesis is a postprandial
phenomenon has received considerable support in the past
several years (7–11). The current results have extended our
previous finding, that fasting RLP concentrations are ele-
vated in patients with type 2 diabetes (4), and have shown
that this finding is accentuated in response to a oral fat load.
More specifically, it appears that significant increases in
fasting and postprandial plasma RLP concentrations are
confined to the subset of patients with type 2 diabetes with
the highest plasma insulin concentrations. As such, our
findings offer a possible mechanism to account for the
association described in patients with type 2 diabetes be-
tween hyperinsulinemia and CHD (23).
Acknowledgment
The authors thank Ms. Naoko Tomie for excellent technical
assistance.
Reprint requests and correspondence: Dr. Akira Tanaka, Third
Department of Internal Medicine, Tokyo Medical and Dental
University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan 113-8519.
E-mail: tanaka.med3@med.tmd.ac.jp.
REFERENCES
1. Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like
lipoproteins in human serum using monoclonal anti B-100 and anti
apoA-1 immunoaffinity mixed gels. Clin Chem Acta 1993;223:53–7.
2. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an
apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins
isolated from human blood plasma with a monoclonal antibody to
apolipoprotein B-100. J Lipid Res 1992;33:369–80.
3. Nakajima K, Okazaki M, Tanaka A, et al. Separation and determi-
nation of remnant-like particles in human serum using monoclonal
antibodies to Apo B-100 and Apo A-1. J Clin Ligand Assay
1996;19:177–83.
4. Watanabe N, Taniguchi T, Taketoh H, et al. Elevated remnant-like
lipoprotein particles in impaired glucose tolerance and type 2 diabetic
patients. Diabetes Care 1999;21:152–6.
5. Abbasi F, McLaughlin T, Lamedola C, et al. Fasting remnant
lipoprotein cholesterol and triglyceride concentrations are elevated in
non-diabetic, insulin resistant, female volunteers. J Clin Endocrinol
Metab 1999;84:3903–6.
6. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circula-
tion 1979;60:473–85.
7. Simons LA, Dwyer T, Simons J, et al. Chylomicrons and chylomicron
remnants in coronary artery disease: a case-control study. Atheroscle-
rosis 1987;65:181–9.
8. Simpson HS, Williamson CM, Olivecrona T, et al. Postprandial
lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;
85:193–202.
9. Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyc-
eride metabolism and coronary artery disease: studies in the postpran-
dial state. Arterioscler Thromb 1992;12:1336–45.
10. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression
of coronary artery disease evaluated by angiography and clinical events.
Circulation 1993;88:2762–70.
11. Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A.
HDLs and alimentary lipemia: studies in men with previous myocar-
dial infarction at young age. Arterioscler Thromb 1993;13:11–22.
12. Jeppesen J, Hollenbeck CB, Zhou M-Y, et al. Relation between
insulin resistance, hyperinsulinemia, post heparin plasma lipoprotein
lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc
Biol 1995;15:320–1.
13. The Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus. Report of the expert committee on the diagnosis
and classification of diabetes mellitus. Diabetes Care 1998;21:S5–S19.
14. Tanaka A, Tomie N, Nakano T, et al. Measurement of postprandial
remnant-like particles (RLPs) following a fat-loading test. Clin Chem
Acta 1998;275:43–52.
15. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic
determination of total serum cholesterol. Clin Chem 1974;20:470–5.
16. Wahlfield AW. Triglyceride determination after enzymatic hydrolysis.
In: Bergmeyer HU, editor. Method of Enzymatic Analysis. New York,
NY: Academic, 1974;1831–5.
17. Gordon T, Castelli WP, Hjorland MC, Kannel WB, Dawber TR.
High density lipoprotein as a prospective factor against coronary heart
disease: the Framingham study. Am J Med 1977;62:707–14.
18. Hengartner H, Zuber H. Isolation and characterization of a thermo-
philic glucokinase from Bacillus stearothermophilus. FEBS Lett 1973;
37:212–6.
19. Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody
precipitate. Biochem J 1963;88:137–46.
20. Ikeda Y, Takagi A, Ohkaru Y, et al. A sandwich-enzyme immunoassay
for the quantification of lipoprotein lipase and hepatic triglyceride
lipase in human post heparin plasma using monoclonal antibodies to
the corresponding enzyme. J Lipid Res 1990;31:1911–24.
21. Kitahara M, Shinomiya M, Shirai K, Saito Y, Yoshida S. Frequency
and role of apo E pheonotype in familial hypercholesterolemia and
nonfamilial hyperlipidemia in the Japanese. Atherosclerosis 1990;82:
197–204.
22. UK Prospective Diabetes Study Group. Tight blood pressure control
and risk of macrovascular and microvascular complications in type 2
diabetes: UKPDS 38. Br Med J 1998;317:703–13.
23. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk
factors clustering with endogenous hyperinsulinemia predict death
from coronary heart disease in patients with type II diabetes. Diabe-
tologia 2000;43:148–55.
1632 Ai et al. JACC Vol. 38, No. 6, 2001
Plasma Insulin and RLP Concentration November 15, 2001:1628–32
